Cargando…
Emerging infectious disease laboratory and diagnostic preparedness to accelerate vaccine development
Rapid vaccine development in response to an outbreak of a new emerging infectious disease (EID) is a goal targeted by public health agencies worldwide. This goal becomes more complicated when there are no standardized sets of viral and immunological assays, no accepted and well-characterized samples...
Autor principal: | Roberts, Christine C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816404/ https://www.ncbi.nlm.nih.gov/pubmed/31268394 http://dx.doi.org/10.1080/21645515.2019.1634992 |
Ejemplares similares
-
Rabies in Our Neighbourhood: Preparedness for an Emerging Infectious Disease
por: Ward, Michael P., et al.
Publicado: (2021) -
Implementation and expansion of laboratory capacity for molecular diagnostics in response to COVID‐19 and preparedness for other emerging infectious diseases in the Islamic Emirate of Afghanistan
por: Khan, Murad Momin, et al.
Publicado: (2023) -
Biological weapons: Hospital preparedness to bioterrorism and other infectious disease emergencies
por: Ippolito, G., et al.
Publicado: (2006) -
CMC Strategies and Advanced Technologies for Vaccine Development to Boost Acceleration and Pandemic Preparedness
por: Castellanos, Maria Monica, et al.
Publicado: (2023) -
Lessons from the Ebola Outbreak: Action Items for Emerging Infectious Disease Preparedness and Response
por: Jacobsen, Kathryn H., et al.
Publicado: (2016)